3M
3M0.F Meiji Holdings Co. Ltd
- Market cap
- EUR 6.40B
- P/E
- 30.3x
- P/B
- 1.48x
- ROE
- 7.9%
- Dividend yield
- 2.49%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 3M0.F undervalued?
Graham number3M0.F trades 41.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Meiji Holdings Co. Ltd fundamental analysis
No fundamental analysis for Meiji Holdings Co. Ltd yet.
Meiji Holdings Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Meiji Holdings Co. Ltd
Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system d…
Full company profileMeiji Holdings Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Meiji Holdings Co. Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.24T | 1.24T | 1.25T | 1.25T | 1.19T | 1.01T | 1.06T | 1.11T | 1.15T | 1.17T | 1.16T |
| Gross Profit | 461B | 455B | 457B | 463B | 450B | 323B | 307B | 327B | 339B | 359B | 355B |
| Operating Income | 88.4B | 94.7B | 98.4B | 103B | 106B | 92.9B | 75.4B | 84.3B | 84.7B | 93.3B | 90.7B |
| EBITDA | - | 140B | 140B | 145B | 152B | 179B | 149B | 143B | 138B | 124B | 148B |
| Net Income | 60.8B | 61.3B | 61.9B | 67.3B | 65.7B | 87.5B | 69.4B | 50.7B | 50.8B | 35.1B | 61.1B |
| EPS | 415 | 423 | 427 | 464 | 452 | 621 | 249 | 182 | 188 | 129 | 225 |
| Balance Sheet | |||||||||||
| Total Assets | 884B | 928B | 1.00T | 999B | 1.07T | 1.12T | 1.14T | 1.21T | 1.18T | 1.26T | 1.29T |
| Total Liabilities | 427B | 432B | 444B | 401B | 408B | 404B | 385B | 417B | 393B | 444B | 468B |
| Shareholders' Equity | 449B | 487B | 527B | 563B | 621B | 673B | 712B | 747B | 748B | 773B | 772B |
| Cash & Short-term Investments | 24.8B | 27.6B | 25.4B | 37.4B | 40.3B | 67.4B | 63.5B | 107B | 78.2B | 69.2B | 86.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 81.9B | 109B | 112B | 114B | 124B | 128B | 85.0B | 108B | 69.0B | 56.5B | 58.9B |
| Capital Expenditure | 48.7B | 69.8B | 67.2B | 68.2B | 63.0B | 88.3B | 72.2B | 53.4B | 56.6B | 104B | 62.5B |
| Free Cash Flow | - | 37.0B | 40.9B | 43.0B | 55.8B | 34.4B | 12.8B | 54.5B | 12.4B | -47.2B | -3.63B |
| Ratios | |||||||||||
| ROE | 13.5% | 12.6% | 11.7% | 12.0% | 10.6% | 13.0% | 9.8% | 6.8% | 6.8% | 4.5% | 7.9% |
| ROA | 6.9% | 6.6% | 6.2% | 6.7% | 6.2% | 7.8% | 6.1% | 4.2% | 4.3% | 2.8% | 4.8% |
| Net Profit Margin | 4.9% | 4.9% | 4.9% | 5.4% | 5.5% | 8.6% | 6.5% | 4.6% | 4.4% | 3.0% | 5.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Meiji Holdings Co. Ltd dividends
- Dividend yield
- 2.49%
- Forward dividend
- 0.62 EUR
- Payout ratio
- 79.0%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 27.7B | 102 | 79.0% |
| 2025 | JPY 26.8B | 99 | 52.7% |
| 2024 | JPY 26.4B | 95 | 52.2% |
| 2023 | JPY 24.6B | 88 | 35.4% |
| 2022 | JPY 23.9B | 170 | 27.3% |
| 2021 | JPY 22.4B | 155 | 34.2% |
| 2020 | EUR 21.0B | 145 | 31.2% |
| 2019 | EUR 19.9B | 137 | 32.2% |
| 2018 | EUR 17.8B | 123 | 29.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Mar 30, 2023.
Who owns Meiji Holdings Co. Ltd
- Insiders 6.62%
- Institutions 35.05%
- Public & others 58.33%
- Shares outstanding 271M
- Free float 256M
Meiji Holdings Co. Ltd company profile
- Company name
- Meiji Holdings Co. Ltd
- Ticker
- 3M0.F
- ISIN
- JP3918000005
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 17,103
- Fiscal year end
- March
- Address
- 2-4-16, Kyobashi, Chuo, Japan, 104-0031
- Phone
- 81 3 3273 4001
- Website
- meiji.com
About Meiji Holdings Co. Ltd
Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, and animal health products. The company was founded in 1916 and is headquartered in Chuo, Japan.
Meiji Holdings Co. Ltd management
10- Mr. Katsunari MatsudaCEO, President & Representative Director · born 1957
- Mr. Bunjiro YaoCOO of Food Segment, Executive Officer & Director · born 1961
- Mr. Jun HishinumaCFO, Senior Managing Executive Officer & Director · born 1965
- Masashi TanakaGeneral Manager of IR Dept
- Mr. Toshiyasu SekineExecutive Officer & Chief Human Resource Officer · born 1971
- Mr. Toshiaki NagasatoCOO of Pharma Segment, Executive Officer & Director · born 1957
- Mr. Shougo OhishiExecutive Officer & Chief Sustainability Officer · born 1964
- Takefumi KogaExecutive Officer & Chief Digital Officer
- Ms. Keiko KawahataExecutive Officer of Wellness Science Labs · born 1966
- Koshi SakamotoGeneral Manager of Intellectual Property Strategy Dept.